Extracellular vesicles are the amazon packages of our body, and every cell is a warehouse able to ship 🚚 and receive cargo 📦. Hematopoietic stem cell behaviour in our bones 🦴 changes with contact of these cargo containing spheres!! Come hear more at poster 231 tuesday #TMM2019
“This year’s 40 Under 40 recipients reflect the range of experiences, perspectives and expertise that make our city such a special place to live and work. Congratulations to all recipients," said Mayor Bryan Paterson. #YGK
See the recipients here: https://t.co/C7ya3RAfyo
Congrats Dr Abraham & students Grenier-Pleau, & Wells @queensutime on article https://t.co/KWfbjlrIEV identifying extracellular vesicle (EV)-defined niches in the haematopoietic system of humans. Novel implications of EV-demarcated nano-niches for human immunity/hematopoiesis!
“Our bladder cancer research program is unique in that it allows trainees to learn from each other’s projects." Dr. Madhuri Koti (Biomedical and Molecular Sciences), principal investigator at Queen's @QueensuSCRI & her team are advancing critical bladder cancer research w/ support from @TerryFoxCanada: https://t.co/4mbLbfW00g
Beyond grateful to have had the opportunity to obtain my PhD under the supervision of Dr. Sheela Abraham at Queen's University! Looking forward to the next chapter! 😊 ✨️ science rocks!
Today we announced a $25M gift from Cara & Murray Sinclair to boost cancer research, build new facilities, & launch training programs. The Queen’s Cancer Research Institute is renamed the Cara & Murray Sinclair Cancer Research Institute (SCRI). #queensu https://t.co/MvRmYDylYO
Had an incredible time at #KSHemato24 sharing my work as a member of the Abraham Lab, with talented scientists across the world in beautiful #Keystone Colorado! Can't wait until our next adventure!
Such an honor to say that we (@BenLok@IacovosMichael @CarolSchuurmans @hansenhe7 @RenwickLab @SupremeHaggis @TracyMcgaha @kathrintyryshkin) are lucky recipients of a TFRI PPG . This will see @Sunnybrook @QueensCRI and @UHN synergize to tackle neuroendocrine cancers. 🦓
For me, the biggest question in our field is can we predict who with clonal hematopoiesis is most at-risk for progression to blood cancer.
This work makes an important step towards that goal. Congrats to @Lachelle_Dawn, Ben Ebert and all authors https://t.co/7PCDJaCAZj
What an honor to be a part of this outstanding workshop on engineering #ExtracellularVesicles for treating HLBS diseases, hosted by @nih_nhlbi and chaired by Stephen Y. Chan and @SaumyaDas_Lab, and to work with @PrithuSundd and co-authors on this informative white paper.
🧵Excited to announce first #ExtracellularVesicle paper by @JunckerLab.
EVs carry proteins both in- and out-side, but how to measure them all while preserving their co-localization?
Come @rosalie_martel and EVPio
Featured at #ISEV Webinar see end of 🧵
https://t.co/KHQCbsSlRu
We need better risk prediction models for which people with clonal hematopoiesis are most at risk for progression to neoplasia.@Lachelle_Dawn presented a new risk score, CHRS, based on 10+K w/ CHIP/CCUS from 193K people in UK Biobank, on behalf of Ebert lab & collaborators.#ASH22
Strictly don't-miss for the next #EVClub but at a DIFFERENT TIME: 8 PM EST, Tuesday, Dec 13: "Big and Small EVs - From Labeling, Dosage, & Size to Biodistribution & Function" w/ @CharlesLAILab Need the login? Sign up: https://t.co/wl8USvTmxM @IsevComms @biorxivpreprint@LabWitwer